Polycythemia vera: Updated Onkopedia Guidelines recommend Interferon alfa as preferred First-line Treatment

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Sunitinib plus interferon-alfa in the first-line treatment for metastatic renal cell carcinoma (mRCC): results of a dose-finding study
    Kondagunta, G. V.
    Hudes, G.
    Figlin, R.
    Wilding, G.
    Hariharan, S.
    Kempin, S.
    Fayyad, R.
    Hoosen, S.
    Motzer, R. J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 305 - 305
  • [32] Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: A phase II study of the Southwest Oncology Group
    Ryan, Christopher W.
    Goldman, Bryan H.
    Lara, Primo N., Jr.
    Mack, Philip C.
    Beer, Tomasz M.
    Tangen, Catherine M.
    Lemmon, Dianne
    Pan, Chong-Xian
    Drabkin, Harry A.
    Crawford, E. David
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3296 - 3301
  • [33] Cost-Effectiveness Analysis of Sunitinib versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore
    Pruis, Sil-ling
    Aziz, Mohamed Ismail Abdul
    Pearce, Fiona
    Tan, Min Han
    Wu, David Bin-Chia
    Ng, Kwong
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (02) : 126 - 133
  • [34] Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma
    Escudier, Bernard
    Szczylik, Cezary
    Hutson, Thomas E.
    Demkow, Tomasz
    Staehler, Michael
    Rolland, Frederic
    Negrier, Sylvie
    Laferriere, Nicole
    Scheuring, Urban J.
    Cella, David
    Shah, Sonalee
    Bukowski, Ronald M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1280 - 1289
  • [35] Guidelines of the French Society of Otorhinolaryngology (SFORL). First-line treatment of epistaxis in adults
    Bequignona, E.
    Verillaud, B.
    Robard, L.
    Michel, J.
    Escabasse, V. Pruliere
    Crampette, L.
    Malard, O.
    Malard, O.
    Crampette
    Achache, M.
    Lamrani, Y. Alaoui
    Babin, Ardilloni E.
    Sollier, C. Bal Dit
    Bequignon, E.
    Borsik, M.
    Castillo, L.
    Coste, A.
    Debry, C.
    Dessi, P.
    Drouet
    Dufour, X.
    Dupuis-Girod, S.
    Faure, F.
    Gallet, P.
    Guldman, R.
    Houdart, E.
    Jankowski, R.
    Jegoux, F.
    Leble, S.
    Michel, J.
    Mortuaire, G.
    Mouchon, E.
    Page, C.
    Escabasse, V. Pruliere
    Robard
    Roux, A.
    Saint Maurice, J. P.
    Sarlon, G.
    Strunski, V.
    Treyillot, V.
    Verillaud, B.
    Vironneau, P.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2017, 134 (03) : 185 - 189
  • [36] Updated Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Elderly Advanced NSCLC Patients
    Shen, B.
    Pan, B.
    Wu, Y.
    Shi, L.
    Gao, J.
    Du, X.
    Feng, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S317 - S318
  • [37] First-line treatment algorithm and guidelines in center-involving diabetic macular edema
    Kodjikian, Laurent
    Bellocq, David
    Bandello, Francesco
    Loewenstein, Anat
    Chakravarthy, Usha
    Koh, Adrian
    Augustin, Albert
    de Smet, Marc D.
    Chhablani, Jay
    Tufail, Adnan
    Garcia-Layana, Alfredo
    Sudhalkar, Aditya
    Mathis, Thibaud
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (06) : 573 - 584
  • [38] First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelines
    El Bouzidi, Kate
    Jose, Sophie
    Phillips, Andrew N.
    Pozniak, Anton
    Ustianowski, Andrew
    Gompels, Mark
    Winston, Alan
    Schaap, Ab
    Dunn, David T.
    Sabin, Caroline A.
    AIDS, 2020, 34 (12) : 1823 - 1831
  • [39] Physician's attitude against COPD guidelines and the choice of first-line treatment for COPD
    Baha, Ayse
    Kokturk, Nurdan
    RESPIRATORY MEDICINE, 2021, 176
  • [40] Economic evaluations of sunitinib versus interferon-alfa (IFN-α) in first-line metastatic renal cell carcinoma (mRCC)
    Remak, E.
    Mullins, C. D.
    Akobundu, E.
    Charbonneau, C.
    Woodruff, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345